510(k) Report

510(k) · Cleared

Cleared

Neb-90 Large Volume Medication Nebulizer

K080657510(k) TraditionalCleared Jun 30, 2008115-day reviewClass II21 CFR 868.5630

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medi Nuclear Corp., Inc. · CAF Nebulizer (Direct Patient Interface)

Cleared on Jun 30, 2008 as substantially equivalent to K915075 (Medi Nuclear Corp., Inc., 1992) and 1 other predicate after a 115-day review. Its family tree reaches back 1 generation to 1992.

Decided
Jun 30, 2008
Review
115 days
Class
Class II
Product code
CAF
Recalls
None
Predicates
2

Its longest line of descent runs back 1 generation to K915075 (1992). 2 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 1998: 1 other ancestorK915075 · Nebulizer (Direct Patient Interface) · Medi Nuclear Corp., Inc. · 199219901995200020052010
Other ancestors, by generation 1 generation back: 1 other ancestor K915075 · Nebulizer (Direct Patient Interface) · Medi Nuclear Corp., Inc. · 19920
  1. Root · 1 generation backK915075 Nebulizer (Direct Patient Interface)Medi Nuclear Corp., Inc. · 1992
  2. This deviceK080657 Neb-90 Large Volume Medication NebulizerMedi Nuclear Corp., Inc. · 2008
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K915075Nebulizer (Direct Patient Interface)Medi Nuclear Corp., Inc.1992—
0 (this device)K080657Neb-90 Large Volume Medication NebulizerMedi Nuclear Corp., Inc.2008—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199810
FIG. 1 — Lineage of K080657, 1992–2008Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CAF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CAF device

  1. #1 K260270 FindAir ONE for pMDI (FAO-MDI-V12-GRE-001)score 13.3 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K915075Nebulizer (Direct Patient Interface)
Summary page 1
…edication Nebulizer (LVN), Hereinafter referred to as "Neb-90" 3. PREDICATE DEVICE: Medi/Nuclear Neb-3A Patient Nebulizer (K915075) Smiths Medical - DHD Health Flo-Mist [B&B Medical Technologies Inc. Hope Nebulizer (K980407]…
Medi Nuclear Corp., Inc.1992—
*K980407Hope Nebulizer
Summary page 1
…PREDICATE DEVICE: Medi/Nuclear Neb-3A Patient Nebulizer (K915075) Smiths Medical - DHD Health Flo-Mist [B&B Medical Technologies Inc. Hope Nebulizer (K980407] Page 3 of 39 Neb-90 Submission 510(k) Premarket Notification (K08…
B&B Medical Technologies, Inc.1998—
*—Smiths Medical - DHD Health Flo-Mist
Named without a submission number
—

Also cleared against K915075: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • None of the 2 ancestors has a recall.
  • 1 other device also cites its predicate K915075.

How does its category compare?

All CAF devices

CAF Nebulizer (Direct Patient Interface): FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.

FDA decisions per year · CAF

7in 2025

2007: 182008: 122009: 82010: 102011: 102012: 92013: 92014: 92015: 82016: 52017: 82018: 92019: 32020: 62021: 82022: 42023: 82024: 42025: 72026 (partial year): 2
2007high 18 (2007) · low 3 (2019)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CAF

211in 2025

2007: 98 days median2008: 123 days median2009: 163 days median2010: 114 days median2011: 157 days median2012: 126 days median2013: 238 days median2014: 151 days median2015: 186 days median2016: 186 days median2017: 253 days median2018: 161 days median2019: 266 days median2020: 219 days median2021: 324 days median2022: 176 days median2023: 279 days median2024: 251 days median2025: 211 days median
2007high 324 (2021) · low 98 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CAF

1in 2018

2007: 12011: 12014: 52015: 32016: 12017: 14, 13 Class I2018: 1
2007high 14 (2017) · low 0 (2008)2026

Class I (13 since 2007) Class II/III not classified

Adverse event reports per year · CAF

191in 2025

2007: 262008: 112009: 152010: 372011: 2372012: 1382013: 2172014: 1232015: 1662016: 2012017: 2562018: 1622019: 1852020: 1172021: 1612022: 552023: 1072024: 1022025: 191
2007high 256 (2017) · low 11 (2008)2025

MAUDE reports naming product code CAF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071898126
200812123011
20098163015
201010114037
2011101571237
201291260138
201392380217
201491515123
201581863166
201651861201
2017825314 (13)256
201891611162
201932660185
202062190117
202183240161
20224176055
202382790107
202442510102
202572110191
20262—0—

What is it indicated for?

The Neb-90TM Large Volume Medication Nebulizer is indicated for the continuous aerosol administration of respiratory medication (inhalable solution) including, but not necessarily limited to, beta adrenergic bronchodilator (albuterol sulfate) and/or a wetting agent such as sodium chloride solution (saline) that is used for the treatment of respiratory and related diseases and conditions including, but not necessarily limited to asthma, COPD, bronchiolitis and cystic fibrosis.

The Neb-90TM Large Volume Medication Nebulizer is for use in hospital Emergency Department, ICU or other similar settings for delivery of aerosolized medication to patients undergoing severe respiratory distress.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K080657: Neb-90 Large Volume Medication Nebulizer.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K080657

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026